NTRP - NextTrip Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
NextTrip Inc.
Neurotrope Inc is biopharmaceutical company with product candidates in pre-clinical and clinical development. It is engaged in developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease.
IPO Date: May 17, 2002
Sector: Consumer Cyclical
Industry: Travel Services
Market Cap: $26.85M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.19 | 4.68%
Avg Daily Range (30 D): $0.09 | 5.79%
Avg Daily Range (90 D): $0.09 | 4.92%
Institutional Daily Volume
Avg Daily Volume: .11M
Avg Daily Volume (30 D): .08M
Avg Daily Volume (90 D): .13M
Trade Size
Avg Trade Size (Sh.): 289
Avg Trade Size (Sh.) (30 D): 231
Avg Trade Size (Sh.) (90 D): 163
Institutional Trades
Total Institutional Trades: 2
Avg Institutional Trade: $1.03M
Avg Institutional Trade (30 D): $M
Avg Institutional Trade (90 D): $M
Avg Institutional Trade Volume: .14M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.42M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 188.43K
 
News
Jul 19, 2024 @ 9:31 PM
NextTrip faces Nasdaq compliance issues over filin...
Source: Lina Guerrero
Financials
  TTM Q4 2026 FY 2026
Basic EPS $-1.82 $-.43 $-1.82
Diluted EPS $-1.82 $-.43 $-1.82
Revenue $3.72M $1.62M $3.72M
Gross Profit $.65M $.23M $.65M
Net Income / Loss $-15.91M $-5.28M $-15.91M
Operating Income / Loss $-16.37M $-5.44M $-16.37M
Cost of Revenue $3.06M $1.39M $3.06M
Net Cash Flow $.63M $-.73M $.63M
PE Ratio    
Splits
Sep 22, 2023 1:20
Feb 15, 2017 1:2
Jan 12, 2017 32:1
Mar 17, 2016 1:100